Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CMT1A duplicated region transcript 7 (CDRT7) is a long intergenic non-protein coding RNA (lincRNA) located on chromosome 17p12, within the 1.4-Mb CMT1A/HNPP duplication/deletion region[1][3][4][5][6]. It consists of three exons and spans 767 bp[1]. It does not encode a protein, with multiple assessments (CPAT, PRIDE, PhyloCSF) indicating non-coding potential[1]. While best characterized as a genomic element in the context of structural variation regions involving peripheral neuropathies (notably Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsy), there is no established direct therapeutic targeting or clear biological function, though some databases list a potential association with Autism Spectrum Disorder based on genomic studies[4][5]. No interacting drugs, mechanisms of action, or biomarker roles are currently described for this lincRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CMT1A duplicated region transcript 7 (CDRT7).